Pharmacological and Psychosocial Treatments in Schizophrenia provides a succinct clinical overview of key areas pertinent to the holistic treatment of people with schizophrenia and, in particular, puts firmly back onto the agenda the importance of psychosocial treatments. The latest data concerning the newer antipsychotic agents and clinical guidelines for their use are reviewed. The real emphasis, however, is on the psychosocial interventions for specific aspects of schizophrenia symptomatology and disability that have been shown to offer major benefits to recovery in the disorder, and yet have failed to have a high profile in the literature, as more effective biological treatments have become available. This book offers practical guidance on effective strategies for use in both clinical settings and in the family context, placing the patient (and their family) once again at the centre of therapeutic endeavours. Encouraging professionals to offer a broader therapeutic approach, this book will offer real hope to therapists, patients and families of what can be achieved if psychosocial interventions complement the many psychopharmacological treatments available today. Key topics include: female patients, treatment resistance, the substance abuser patient, family intervention, helping the patient at work, managing violent behaviour, first episode psychosis and rating scales in schizophrenia.

A fully revised and updated edition of this unique and authoritative reference The award-winning A Guide to Treatments that Work , published in 1998, was the first book to assemble the numerous advances in both clinical psychology and psychiatry into one accessible volume. It immediately established itself as an indispensable reference for all mental health practitioners. Now in a fully updated edition,A Guide to Treatments that Work, Second Edition brings together, once again, a distinguished group of psychiatrists and clinical psychologists to take stock of which treatments and interventions actually work, which don't, and what still remains beyond the scope of our current knowledge. The new edition has been extensively revised to take account of recent drug developments and advances in psychotherapeutic interventions. Incorporating a wealth of new information, these eminent researchers and clinicians thoroughly review all available outcome data and clinical trials and provide detailed specification of methods and procedures to ensure effective treatment for each major DSM-IV disorder. As an interdisciplinary work that integrates information from both clinical psychology and psychiatry, this new edition will continue to serve as an essential volume for practitioners of every kind: psychiatrists, psychologists, clinical social workers, counselors, and mental health consultants.

This manual attempts to provide simple, adequate and evidence-based information to health care professionals in primary health care especially in low- and middle-income countries to be able to provide pharmacological treatment to persons with mental disorders. The manual contains basic principles of prescribing followed by chapters on medicines used in psychotic disorders; depressive disorders; bipolar disorders; generalized anxiety and sleep disorders; obsessive compulsive disorders and panic attacks; and alcohol and opioid dependence. The annexes provide information on evidence retrieval, assessment and synthesis and the peer view process.

Reviewing the breadth of current knowledge on schizophrenia, this handbook provides clear, practical guidelines for effective assessment and treatment in diverse contexts. Leading authorities have contributed 61 concise chapters on all aspects of the disorder and its clinical management. In lieu of exhaustive literature reviews, each chapter summarizes the state of the science; highlights key points the busy practitioner needs to know; and lists recommended resources, including seminal research studies, invaluable clinical tools, and more. Comprehensive, authoritative, and timely, the volume will enable professionals in any setting to better understand and help their patients or clients with severe mental illness.

The introduction of antipsychotic agents in the 1950’s substantially improved the treatment of schizophrenia and other psychotic disorders. However, clinical and functional outcomes are still far less than optimal for patients, and have not improved in recent years despite the development of several new antipsychotics. Efficacy rates are further compromised by medication non-adherence, which has been reported to affect more than half of patients. In response to these issues, several non-pharmacological interventions have been developed for the treatment of schizophrenia, such as cognitive behavioral therapy, cognitive remediation, social cognition training and metacognitive approaches. Although these interventions have produced promising results, there is still much controversy regarding their usefulness and applicability in clinical practice. A major impeding factor for their dissemination is possibly a lack of sufficient evidence regarding their specific indications, mechanisms of action, adverse effects, but also practical issues concerning the interpretability of respective clinical studies, such as the choice of outcome variables and control of confounding factors. The present Research Topic includes original research articles and reviews addressing these issues.

This text sets out clear recommendations for healthcare staff (based on the best available evidence) on how to assess and manage adults and young people (aged 14+) who have both psychosis and a substance misuse problem, in order to integrate treatment for both conditions and thus improve their care.

Mental health and substance use disorders affect approximately 20 percent of Americans and are associated with significant morbidity and mortality. Although a wide range of evidence-based psychosocial interventions are currently in use, most consumers of mental health care find it difficult to know whether they are receiving high-quality care. Although the current evidence base for the effects of psychosocial interventions is sizable, subsequent steps in the process of bringing a psychosocial intervention into routine clinical care are less well defined. Psychosocial Interventions for Mental and Substance Use Disorders details the reasons for the gap between what is known to be effective and current practice and offers recommendations for how best to address this gap by applying a framework that can be used to establish standards for psychosocial interventions. The framework described in Psychosocial Interventions for Mental and Substance Use Disorders can be used to chart a path toward the ultimate goal of improving the outcomes. The framework highlights the need to (1) support research to strengthen the evidence base on the efficacy and effectiveness of psychosocial interventions; (2) based on this evidence, identify the key elements that drive an intervention's effect; (3) conduct systematic reviews to inform clinical guidelines that incorporate these key elements; (4) using the findings of these systematic reviews, develop quality measures - measures of the structure, process, and outcomes of interventions; and (5) establish methods for successfully implementing and sustaining these interventions in regular practice including the training of providers of these interventions. The recommendations offered in this report are intended to assist policy makers, health care organizations, and payers that are organizing and overseeing the provision of care for mental health and substance use disorders while navigating a new health care landscape. The recommendations also target providers, professional societies, funding agencies, consumers, and researchers, all of whom have a stake in ensuring that evidence-based, high-quality care is provided to individuals receiving mental health and substance use services.

Like its predecessors, this fourth edition of A Guide to Treatments That Work offers detailed chapters that review the latest research on pharmacological and psychosocial treatments that work for the full range of psychiatric and psychological disorders, written in most instances by clinical psychologists and psychiatrists who have been major contributors to that literature. Similarly, the standards by which the authors were asked to evaluate the methodological rigor of the research on treatments have also remained the same. Each chapter in A Guide to Treatments That Work follows the same general outline: a review of diagnostic cues to the disorder, a discussion of changes in the nomenclatures from DSM-IV to DSM-5, and then a systematic review of research, most of which has been reported within the last few years, that represents the evidence base for the treatments reviewed. In all, 26 of the volume's 28 chapters review the evidence base for 17 major syndromes. Featuring this coverage is a Summary of Treatments that Work, an extended matrix offering a ready reference by syndrome of the conclusions reached by the chapter authors on treatments that work reviewed in their chapters. New to this edition are two chapters at the beginning of the book. Chapter 1 details two perplexing issues raised by critics of DSM-5: the unrealized potential of neuroscience biomarkers to yield more accurate and reliable diagnoses and the lingering problem of conflicts of interest in pharmaceutical research. Chapter 2 contrasts Native American and western ways of identifying effective treatments for mental and physical disorders, concluding that "evidence-informed culture-based" interventions sometimes constitute best practices in Native communities. Two chapters detailing pharmacological treatments for pediatric bipolar disorder (Chapter 9) and pediatric depressive disorder (Chapter 12) have also been added. More than three quarters of the chapters are written by colleagues who also contributed to most or all of the previous editions. Hence, this new edition provides up-to-date information on the quality of research on treatment efficacy and effectiveness provided by individuals who know the research best.

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

There has been a growing trend in psychiatry to emphasize pharmacological approaches in the treatment of schizophrenia. Despite the considerable influence of psychosocial factors on the course of the disorder, relatively little emphasis has been placed on psychosocial treatment approaches. The aim of the book is to provide authoritative information on a broad spectrum of treatment approaches to improve role functioning and coping skills. Taking into account results of long-term outcome studies carried out in recent years, this book brings together a diversity of controlled research efforts conducted by leading experts in their specific fields. Considering that the major disability attributed to this illness is impairment in social and vocational role functioning, the authors substantiate with efficacious data their theory that antipsychotic medication alone is insufficient in the treatment of patients.